Power wheelchair — group 2 denied as not medically necessary by UnitedHealthcare?

Under UnitedHealthcare's Commercial medical policy, mobility devices including manual wheelchairs, electric wheelchairs, transfer chairs, scooters/power-operated vehicles (POV), canes, and walkers are a covered health care service when medically necessary. The policy aligns with CMS LCD L33789, which establishes that the beneficiary must have a mobility limitation that significantly impairs his/her ability to participate in one or more mobility-related activities of daily living (MRADLs) such as toileting, feeding, dressing, grooming, and bathing in customary locations in the home — a limitation that prevents the beneficiary from accomplishing an MRADL entirely, places the beneficiary at heightened risk of morbidity or mortality, or prevents completing an MRADL within a reasonable time frame ; additionally, the mobility limitation cannot be sufficiently and safely resolved by an appropriately fitted cane or walker, and the beneficiary does not have sufficient upper extremity function to self-propel an optimally-configured manual wheelchair in the home to perform MRADLs during a typical day. Use of a power wheelchair must significantly improve the beneficiary's ability to participate in MRADLs and the beneficiary will use it in the home (for severe cognitive/physical impairments, participation in MRADLs may require caregiver assistance), and the beneficiary has not expressed an unwillingness to use a power wheelchair in the home. For a Group 2 standard PWC, a Group 2 PWC (K0820, K0821, K0822, K0823, K0824, K0825, K0826, K0827, K0828, K0829) is covered if all of the coverage criteria (a)-(e) for a PWC are met and the wheelchair is appropriate for the beneficiary's weight. For a Group 2 Single Power Option PWC, all coverage criteria (a)-(e) must be met, plus the beneficiary meets coverage criteria for a power tilt or recline seating system OR requires a drive control interface other than a hand or chin-operated standard proportional joystick (examples include head control, sip and puff, switch control) , and a specialty evaluation must be performed by a licensed/certified medical professional (PT, OT, or practitioner with rehab wheelchair training) with no financial relationship with the supplier, and the wheelchair must be provided by a supplier that employs a RESNA-certified Assistive Technology Professional (ATP) with direct, in-person involvement in the wheelchair selection. DME has a reasonable useful lifetime (RUL) of 5 years , and payment is made for only one wheelchair at a time; backup chairs are denied as not reasonable and necessary.

- **Document MRADL impact in detail**: Provide a clinician note specifying which MRADLs (toileting, feeding, dressing, grooming, bathing) the patient cannot complete or completes only with heightened morbidity/mortality risk, directly mapping to the LCD L33789 definition of a qualifying mobility limitation . - **Stepwise rule-out of lesser devices**: Submit PT/OT documentation explaining why a cane, walker, and optimally-configured manual wheelchair each fail — addressing strength, endurance, ROM, coordination, pain, or upper-extremity deformity per the LCD's enumerated upper-extremity assessment factors (strength, endurance, range of motion, coordination, pain, deformity or absence of one or both upper extremities) . - **Provide compliant face-to-face and WOPD**: Attach the dated face-to-face mobility examination note and the signed Standard Written Order before delivery; cite Final Rule 1713's requirement of a face-to-face encounter and Written Order Prior to Delivery as satisfied. - **Include RESNA ATP and independent specialty evaluation**: For Group 2 Single Power Option chairs, include both the ATP credential attestation and the independent PT/OT specialty evaluation, satisfying the requirement that a licensed PT/OT with no financial relationship to the supplier perform the specialty evaluation and that a RESNA-certified ATP have direct involvement in wheelchair selection . - **Demonstrate in-home use**: Document home assessment showing adequate access between rooms and maneuvering space, and explicitly state the device will be used in the home to meet the requirement that the beneficiary's home provides adequate access and that the power wheelchair will significantly improve the beneficiary's ability to participate in MRADLs in the home . - **Justify Group 2 over Group 1**: If denied as needing only a Group 1, document the patient's weight against capacity limits or, for Single Power Option, the medical necessity of power tilt/recline (e.g., pressure ulcer risk, inability to perform a functional weight shift) or alternative drive control interface per LCD L33789 Group 2 Single Power Option criteria including need for non-standard drive control such as head control, sip and puff, or switch control . - **Replacement vs. repair**: For replacement requests, document the 5-year RUL and that the existing chair cannot be repaired or no longer meets the patient's needs, citing the 5-year reasonable useful lifetime standard and UHC's allowance for upgrades when the member's condition changes (e.g., impaired function necessitates an upgrade to a power wheelchair from a manual one) .

## Why UnitedHealthcare Denies a Group 2 Power Wheelchair on Medical-Necessity Grounds

UHC's medical-necessity review for Group 2 power wheelchairs examines whether you have a severe enough mobility limitation that cannot be adequately addressed by a cane, walker, manual wheelchair, or a lower-classification power device. UHC typically applies criteria drawn from the applicable Medicare Local Coverage Determination (LCD) for power mobility devices, even for commercial plans. Denials often occur when the documentation submitted does not fully capture the functional severity of the limitation, the face-to-face clinical evaluation is missing or incomplete, or when the ordering physician did not conduct or document the required mobility assessment.

## Why This Denial Is Appealable

Medical-necessity denials for complex rehabilitation equipment are frequently overturned when the clinical record is completed and submitted properly. UHC reviewers are working from what was submitted — not from your full medical picture. A thorough face-to-face evaluation by a licensed physical or occupational therapist, combined with a detailed letter of medical necessity from your prescribing physician, and documentation showing why lesser equipment is inadequate, addresses the core of the denial.

## Federal Appeal Framework

• Internal appeal (ERISA §503 / state law): File within the deadline shown on your denial letter — typically 180 days. A full-and-fair review requires UHC to consider all submitted evidence.
• External review (ACA §2719): After a final internal denial, an independent IRO reviews the clinical determination within approximately four months. IROs evaluate the medical evidence de novo — a strong clinical record can prevail even after internal denial.
• Expedited review: If your condition creates urgent health risk (e.g., inability to independently perform activities of daily living, skin-integrity risk from inadequate positioning), request expedited review and document the clinical urgency in writing.
• Medicare Advantage: If applicable, the CMS appeals process applies; the Medicare LCD for power mobility devices is directly binding on the plan.

## Documentation to Gather

1. Face-to-face clinical evaluation: A documented examination by your treating physician — or a specialist — specifically assessing your mobility limitation. This is typically a required element under LCD-based criteria and must be performed within a defined period before the order. 2. Physical/occupational therapist assessment: A detailed functional mobility evaluation by a licensed PT or OT documenting: (a) your specific diagnosis and how it limits mobility; (b) why a manual wheelchair or lower-tier power device is inadequate; (c) how a Group 2 power wheelchair will enable you to perform mobility-related activities of daily living in the home. 3. Prescriber letter of medical necessity: Addressed specifically to UHC's medical-necessity criteria, explaining the functional limitation, the inadequacy of lesser alternatives, and why the Group 2 classification is appropriate. 4. Diagnosis and chart records: Supporting the permanent nature of the mobility limitation and its severity. 5. UHC's coverage policy: Pull the exact criteria from UHC's published clinical coverage policy for Group 2 power mobility devices and address each criterion point by point.

## Criteria-Mapping Structure

| UHC Medical-Necessity Criterion | Your Chart Evidence | |---|---| | Severe mobility limitation (permanent/long-term) | [Diagnosis, onset, chart notes confirming permanence] | | Unable to use lesser mobility device | [Therapist assessment documenting why manual/Group 1 is inadequate] | | Face-to-face evaluation completed | [Date, provider, findings documented] | | Group 2 enables home mobility-related ADLs | [Therapist assessment, specific ADL documentation] | | Valid prescription/order | [Prescriber name, date, specifics of order] |

The therapist's written justification addressing why a manual wheelchair or lower-classification device is insufficient is the single most critical document in a Group 2 medical-necessity appeal.